Antimicrobial treatment guidelines for acute bacterial rhinosinusitis - Executive summary

被引：282

作者：

Anon, JB ^{[1
]}

Jacobs, MR ^{[1
]}

Roche, R ^{[1
]}

Poole, MD ^{[1
]}

Merck, D ^{[1
]}

Ambrose, PG ^{[1
]}

Benninger, MS ^{[1
]}

Hadley, JA ^{[1
]}

Craig, WA ^{[1
]}

Andes, DR ^{[1
]}

Bernstein, JM ^{[1
]}

Besser, RE ^{[1
]}

Dowell, SF ^{[1
]}

Drusano, GL ^{[1
]}

Klepser, ME ^{[1
]}

Nicolau, D ^{[1
]}

Radowsky, A ^{[1
]}

Reller, LB ^{[1
]}

Wald, ER ^{[1
]}

Zucker, DR ^{[1
]}

机构：

[1] Sinus & Allergy Hlth Partnership, Washington, DC 20036 USA

来源：

OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2004年 / 130卷 / 01期

关键词：

D O I：

10.1016/j.otohns.2003.12.003

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

引用

页码：1 / 45

页数：45

共 159 条

[1] ADDERSON EE, 2003, 43 INT C ANT AG CHEM
[2] Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives):: A new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens
Agouridas, C
Denis, A
Auger, JM
Benedetti, Y
Bonnefoy, A
Bretin, F
Chantot, JF
Dussarat, A
Fromentin, C
D'Ambrières, SG
Lachaud, S
Laurin, P
Le Martret, O
Loyau, V
Tessot, N
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) : 4080 - 4100
[3] *AHCPR, 1999, DIAGN TREATM AC BACT
[4] Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore
Albanese, BA
Roche, JC
Pass, M
Whitney, CG
McEllistrem, MC
Harrison, LH
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 15 - 21
[5] AMBROSE P, 2003, 43 INT C ANT AG CHEM
[6] New antibiotics in pulmonary and critical care medicine: Focus on advanced generation quinolones and cephalosporins
Ambrose, PG
Owens, RC
[J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 21 (01) : 19 - 32
[7] Continuous vs. intermittent infusion of cefuroxime for the treatment of community-acquired pneumonia
Ambrose, PG
Quintiliani, R
Nightingale, CH
Nicolau, DP
[J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1998, 7 (09) : 463 - 470
[8] Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction
Ambrose, PG
Bhavnani, SM
Cirincione, BB
Piedmonte, M
Grasela, TH
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) : 435 - 440
[9] The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs:: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae
Ambrose, PG
Grasela, DM
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (03) : 151 - 157
[10] Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
Ambrose, PG
Grasela, DM
Grasela, TH
Passarell, J
Mayer, HB
Pierce, PF
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (10) : 2793 - 2797

← 1 2 3 4 5 6 7 8 9 10 →